{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T08:29:35Z","timestamp":1718267375766},"reference-count":81,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Bras Endocrinol Metab"],"published-print":{"date-parts":[[2011,8]]},"abstract":"<jats:p>OBJECTIVES: To determine the prevalence of insulin resistance (IR) in non-diabetic patients with chronic hepatitis C, and to assess the association between IR, laboratory parameters and histological findings. SUBJECTS AND METHODS: Eighty-two patients had their serum analyzed for glucose, lipid profile, C-reactive protein (CRP), ferritin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), HOMA-IR, viral load and HCV genotype. Patients with HOMA-IR levels &gt; 2.5 were considered as carriers of insulin resistance. RESULTS: IR was observed in 27% of patients and was associated with age, waist circumference and body mass index. IR patients were more likely to have more advanced hepatic fibrosis and necroinflammatory activity, higher levels of aminotransferases and liver steatosis than patients without IR. CONCLUSIONS: Insulin resistance is often present in patients with chronic hepatitis C, and this parameter is associated with more advanced HCV-related hepatic fibrosis.<\/jats:p>","DOI":"10.1590\/s0004-27302011000600008","type":"journal-article","created":{"date-parts":[[2011,10,12]],"date-time":"2011-10-12T06:54:56Z","timestamp":1318402496000},"page":"412-418","source":"Crossref","is-referenced-by-count":8,"title":["Insulin resistance in non-diabetic patients with chronic hepatitis C: what does it mean?"],"prefix":"10.1590","volume":"55","author":[{"given":"A\u00e9cio Fl\u00e1vio Meirelles de","family":"Souza","sequence":"first","affiliation":[{"name":"Universidade Federal de Juiz de Fora,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1bio Heleno de Lima","family":"Pace","sequence":"additional","affiliation":[{"name":"UFJF,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00falio Maria Fonseca","family":"Chebli","sequence":"additional","affiliation":[{"name":"UFJF,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lincoln Eduardo Villela Vieira de Castro","family":"Ferreira","sequence":"additional","affiliation":[{"name":"UFJF,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"issue":"suppl 1","key":"ref2","first-page":"S3","article-title":"Epidemiologia da infec\u00e7\u00e3o pelo v\u00edrus da hepatite C no Brasil","volume":"18","author":"Fonseca J","year":"1999","journal-title":"Relat\u00f3rio do Grupo de Estudo da Sociedade Brasileira de Hepatologia. GED. Gastroenterologia Endoscopia Digestiva."},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.284.4.450","article-title":"The natural history of hepatitis C virus infection: host, viral, and environmental factors","volume":"284","author":"Thomas DL","year":"2000","journal-title":"Jama."},{"issue":"Suppl. 2","key":"ref4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2036.2005.02602.x","article-title":"Review article: chronic hepatitis C - natural history and cofactors","volume":"22","author":"Alberti A","year":"2005","journal-title":"Aliment Pharmacol Ther."},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2010.03.015","article-title":"The natural history of hepatitis C infection acquired through injection drug use: meta-analysis and meta-regression","volume":"53","author":"John-Baptiste A","year":"2010","journal-title":"J Hepatol."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0168-8278(00)00097-0","article-title":"Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C","volume":"34","author":"Poynard T","year":"2001","journal-title":"J Hepatol."},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.510300409","article-title":"Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients","volume":"30","author":"Benhamou Y","year":"1999","journal-title":"The Multivirc Group. Hepatology."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1053\/j.gastro.2003.08.032","article-title":"Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression","volume":"125","author":"Hui JM","year":"2003","journal-title":"Gastroenterology."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1478-3231.2010.02397.x","article-title":"Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C","volume":"31S1","author":"Sanyal AJ","year":"2011","journal-title":"Liver Int."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/gut.2004.050302","article-title":"Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C","volume":"54","author":"Fartoux L","year":"2005","journal-title":"Gut."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome - a new world-wide definition: A Consensus Statement from the International Diabetes Federation","volume":"23","author":"Alberti KG","year":"2006","journal-title":"Diab Med"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.bpg.2010.08.005","article-title":"Nonalcoholic fatty liver disease","volume":"24","author":"Krawczyk M","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol."},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.beem.2006.09.007","article-title":"Pathophysiology of insulin resistance","volume":"20","author":"Setsi G","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"6A","key":"ref14","doi-asserted-by":"crossref","first-page":"3s","DOI":"10.1016\/S0002-9343(02)01276-7","article-title":"Beta cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities","volume":"113","author":"LeRoith D","year":"2002","journal-title":"Am J Med."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jhep.2007.11.022","article-title":"Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C","volume":"48","author":"Romero G\u00f3mez M","year":"2008","journal-title":"J Hepatol."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.2337\/dc06-0456","article-title":"Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection","volume":"29","author":"Sim\u00f3 R","year":"2006","journal-title":"Diabetes Care."},{"issue":"2","key":"ref17","first-page":"73","article-title":"La resistencia a la insulina en la hepatitis cr\u00f3nica C","volume":"9","author":"L\u00f3pez RA","year":"2010","journal-title":"GH continuada."},{"key":"ref18","first-page":"80","article-title":"Virahep-C Study Group","volume":"45","author":"Conjeevaram HS","year":"2007","journal-title":"Race, insulin resistance and hepatic steatosis in chronic hepatitis C. Hepatology."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jhep.2008.12.017","article-title":"Insulin resistance predicts response to peginterferon-alpha\/ribavirin combination therapy in chronic hepatitis C patients","volume":"50","author":"Dai CY","year":"2009","journal-title":"J Hepatol."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-2036.2008.03823.x","article-title":"Insulin resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon alpha-2b plus ribavirin","volume":"29","author":"Chu CJ","year":"2009","journal-title":"Aliment Pharmacol Ther."},{"issue":"2","key":"ref21","first-page":"289","article-title":"An algorithm for the grading of activity in chronic hepatitis C","volume":"24","author":"Bedossa P","year":"1996","journal-title":"The METAVIR Cooperative Study Group. Hepatology."},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2001-12925","article-title":"Nonalcoholic steatohepatitis: definition and pathology","volume":"21","author":"Brunt EM","year":"2001","journal-title":"Semin Liver Dis."},{"issue":"16","key":"ref23","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation;International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti KG","year":"2009","journal-title":"Circulation."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2337\/diacare.19.9.998","article-title":"High prevalence of hepatitis C virus infection in diabetic patients","volume":"19","author":"Simo R","year":"1996","journal-title":"Diabetes Care."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.510290235","article-title":"Association of diabetes mellitus and chronic hepatitis C virus infection","volume":"29","author":"Mason AL","year":"1999","journal-title":"Hepatology."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/aje\/kwm061","article-title":"Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study","volume":"166","author":"Wang CS","year":"2007","journal-title":"Am J Epidemiol."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-133-8-200010170-00009","article-title":"Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States","volume":"133","author":"Mehta SH","year":"2000","journal-title":"Ann Intern Med."},{"key":"ref28","first-page":"818","article-title":"Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas","volume":"22","author":"Emoto M","year":"1999","journal-title":"Diabetes","ISSN":"http:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/diacare.23.1.57","article-title":"Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity","volume":"23","author":"Bonora E","year":"2000","journal-title":"Diabetes Care."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jhep.2009.07.008","article-title":"Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin","volume":"51","author":"Grasso A","year":"2009","journal-title":"J Hepatol."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/j.gastro.2007.11.010","article-title":"Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis","volume":"134","author":"Moucari R","year":"2008","journal-title":"Gastroenterology."},{"key":"ref32","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/j.gastro.2004.12.049","article-title":"Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients","volume":"128","author":"Romero-G\u00f3mez M","year":"2005","journal-title":"Gastroenterology."},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s10620-009-0844-y","article-title":"Insulin resistance is common in patients with predominantly genotype 3 chronic hepatitis C","volume":"54","author":"Duseja A","year":"2009","journal-title":"Dig Dis Sci."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1478-3231.2007.01626.x","article-title":"High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C","volume":"28","author":"Hsu C-S","year":"2008","journal-title":"Liver Int."},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1590\/S0004-27302009000200020","article-title":"HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS)","volume":"53","author":"Geloneze B","year":"2009","journal-title":"Arq Bras Endocrinol Metabol","ISSN":"http:\/\/id.crossref.org\/issn\/0004-2730","issn-type":"print"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.tem.2007.02.001","article-title":"Transcriptional regulation of the GLUT4 gene: from PPAR-gamma and FOXO1 to FFA and inflammation","volume":"18","author":"Armoni M","year":"2007","journal-title":"Trends Endocrinol Metab."},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00000441-200512000-00005","article-title":"Fat as an endocrine organ: relationship to the metabolic syndrome","volume":"330","author":"Hutley L","year":"2005","journal-title":"Am J Med Sci."},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1161\/01.HYP.0000185688.81320.4d","article-title":"Body distribution, liver enzymes, and risk of hypertension: evidence from the Western New York Study","volume":"46","author":"Stranges S","year":"2005","journal-title":"Hypertension."},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3748\/wjg.15.1537","article-title":"Hepatitis C virus and type 2 diabetes","volume":"15","author":"Negro F","year":"2009","journal-title":"World J Gastroenterol."},{"key":"ref40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/gut.2005.069757","article-title":"Steatosis in chronic hepatitis C: what does it really matter?","volume":"55","author":"Asselah T","year":"2006","journal-title":"Gut","ISSN":"http:\/\/id.crossref.org\/issn\/0017-5749","issn-type":"print"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s10620-009-1081-0","article-title":"Nonalcoholic Fatty Liver Disease: A Review and Update","volume":"55","author":"Lewis JR","year":"2010","journal-title":"Dig Dis Sci."},{"issue":"17","key":"ref1","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","article-title":"Epidemiology of hepatitis C virus infection","volume":"13","author":"Alter MJ","year":"2007","journal-title":"World J. Gastroenterolol."},{"issue":"suppl 1","key":"ref2","first-page":"S3","article-title":"Epidemiologia da infec\u00e7\u00e3o pelo v\u00edrus da hepatite C no Brasil","volume":"18","author":"Fonseca J","year":"1999","journal-title":"Relat\u00f3rio do Grupo de Estudo da Sociedade Brasileira de Hepatologia. GED. Gastroenterologia Endoscopia Digestiva."},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.284.4.450","article-title":"The natural history of hepatitis C virus infection: host, viral, and environmental factors","volume":"284","author":"Thomas DL","year":"2000","journal-title":"Jama."},{"issue":"Suppl. 2","key":"ref4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2036.2005.02602.x","article-title":"Review article: chronic hepatitis C - natural history and cofactors","volume":"22","author":"Alberti A","year":"2005","journal-title":"Aliment Pharmacol Ther."},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2010.03.015","article-title":"The natural history of hepatitis C infection acquired through injection drug use: meta-analysis and meta-regression","volume":"53","author":"John-Baptiste A","year":"2010","journal-title":"J Hepatol."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0168-8278(00)00097-0","article-title":"Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C","volume":"34","author":"Poynard T","year":"2001","journal-title":"J Hepatol."},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.510300409","article-title":"Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients","volume":"30","author":"Benhamou Y","year":"1999","journal-title":"The Multivirc Group. Hepatology."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1053\/j.gastro.2003.08.032","article-title":"Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression","volume":"125","author":"Hui JM","year":"2003","journal-title":"Gastroenterology."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1478-3231.2010.02397.x","article-title":"Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C","volume":"31S1","author":"Sanyal AJ","year":"2011","journal-title":"Liver Int."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/gut.2004.050302","article-title":"Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C","volume":"54","author":"Fartoux L","year":"2005","journal-title":"Gut."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome - a new world-wide definition: A Consensus Statement from the International Diabetes Federation","volume":"23","author":"Alberti KG","year":"2006","journal-title":"Diab Med"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.bpg.2010.08.005","article-title":"Nonalcoholic fatty liver disease","volume":"24","author":"Krawczyk M","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol."},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.beem.2006.09.007","article-title":"Pathophysiology of insulin resistance","volume":"20","author":"Setsi G","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"6A","key":"ref14","doi-asserted-by":"crossref","first-page":"3s","DOI":"10.1016\/S0002-9343(02)01276-7","article-title":"Beta cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities","volume":"113","author":"LeRoith D","year":"2002","journal-title":"Am J Med."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jhep.2007.11.022","article-title":"Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C","volume":"48","author":"Romero G\u00f3mez M","year":"2008","journal-title":"J Hepatol."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.2337\/dc06-0456","article-title":"Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection","volume":"29","author":"Sim\u00f3 R","year":"2006","journal-title":"Diabetes Care."},{"issue":"2","key":"ref17","first-page":"73","article-title":"La resistencia a la insulina en la hepatitis cr\u00f3nica C","volume":"9","author":"L\u00f3pez RA","year":"2010","journal-title":"GH continuada."},{"key":"ref18","first-page":"80","article-title":"Virahep-C Study Group","volume":"45","author":"Conjeevaram HS","year":"2007","journal-title":"Race, insulin resistance and hepatic steatosis in chronic hepatitis C. Hepatology."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jhep.2008.12.017","article-title":"Insulin resistance predicts response to peginterferon-alpha\/ribavirin combination therapy in chronic hepatitis C patients","volume":"50","author":"Dai CY","year":"2009","journal-title":"J Hepatol."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-2036.2008.03823.x","article-title":"Insulin resistance is a major determinant of sustained virological response in genotype 1 chronic hepatitis C patients receiving peginterferon alpha-2b plus ribavirin","volume":"29","author":"Chu CJ","year":"2009","journal-title":"Aliment Pharmacol Ther."},{"issue":"2","key":"ref21","first-page":"289","article-title":"An algorithm for the grading of activity in chronic hepatitis C","volume":"24","author":"Bedossa P","year":"1996","journal-title":"The METAVIR Cooperative Study Group. Hepatology."},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2001-12925","article-title":"Nonalcoholic steatohepatitis: definition and pathology","volume":"21","author":"Brunt EM","year":"2001","journal-title":"Semin Liver Dis."},{"issue":"16","key":"ref23","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation;International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti KG","year":"2009","journal-title":"Circulation."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2337\/diacare.19.9.998","article-title":"High prevalence of hepatitis C virus infection in diabetic patients","volume":"19","author":"Simo R","year":"1996","journal-title":"Diabetes Care."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.510290235","article-title":"Association of diabetes mellitus and chronic hepatitis C virus infection","volume":"29","author":"Mason AL","year":"1999","journal-title":"Hepatology."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/aje\/kwm061","article-title":"Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study","volume":"166","author":"Wang CS","year":"2007","journal-title":"Am J Epidemiol."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-133-8-200010170-00009","article-title":"Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States","volume":"133","author":"Mehta SH","year":"2000","journal-title":"Ann Intern Med."},{"key":"ref28","first-page":"818","article-title":"Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas","volume":"22","author":"Emoto M","year":"1999","journal-title":"Diabetes","ISSN":"http:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/diacare.23.1.57","article-title":"Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity","volume":"23","author":"Bonora E","year":"2000","journal-title":"Diabetes Care."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jhep.2009.07.008","article-title":"Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin","volume":"51","author":"Grasso A","year":"2009","journal-title":"J Hepatol."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/j.gastro.2007.11.010","article-title":"Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis","volume":"134","author":"Moucari R","year":"2008","journal-title":"Gastroenterology."},{"key":"ref32","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/j.gastro.2004.12.049","article-title":"Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients","volume":"128","author":"Romero-G\u00f3mez M","year":"2005","journal-title":"Gastroenterology."},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s10620-009-0844-y","article-title":"Insulin resistance is common in patients with predominantly genotype 3 chronic hepatitis C","volume":"54","author":"Duseja A","year":"2009","journal-title":"Dig Dis Sci."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1478-3231.2007.01626.x","article-title":"High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C","volume":"28","author":"Hsu C-S","year":"2008","journal-title":"Liver Int."},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1590\/S0004-27302009000200020","article-title":"HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS)","volume":"53","author":"Geloneze B","year":"2009","journal-title":"Arq Bras Endocrinol Metabol","ISSN":"http:\/\/id.crossref.org\/issn\/0004-2730","issn-type":"print"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.tem.2007.02.001","article-title":"Transcriptional regulation of the GLUT4 gene: from PPAR-gamma and FOXO1 to FFA and inflammation","volume":"18","author":"Armoni M","year":"2007","journal-title":"Trends Endocrinol Metab."},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00000441-200512000-00005","article-title":"Fat as an endocrine organ: relationship to the metabolic syndrome","volume":"330","author":"Hutley L","year":"2005","journal-title":"Am J Med Sci."},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1161\/01.HYP.0000185688.81320.4d","article-title":"Body distribution, liver enzymes, and risk of hypertension: evidence from the Western New York Study","volume":"46","author":"Stranges S","year":"2005","journal-title":"Hypertension."},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3748\/wjg.15.1537","article-title":"Hepatitis C virus and type 2 diabetes","volume":"15","author":"Negro F","year":"2009","journal-title":"World J Gastroenterol."},{"key":"ref40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/gut.2005.069757","article-title":"Steatosis in chronic hepatitis C: what does it really matter?","volume":"55","author":"Asselah T","year":"2006","journal-title":"Gut","ISSN":"http:\/\/id.crossref.org\/issn\/0017-5749","issn-type":"print"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s10620-009-1081-0","article-title":"Nonalcoholic Fatty Liver Disease: A Review and Update","volume":"55","author":"Lewis JR","year":"2010","journal-title":"Dig Dis Sci."}],"container-title":["Arquivos Brasileiros de Endocrinologia &amp; Metabologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abem\/v55n6\/a08v55n6.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T00:36:49Z","timestamp":1495845409000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-27302011000600008&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0004-27302011000600008"],"URL":"https:\/\/doi.org\/10.1590\/s0004-27302011000600008","relation":{},"ISSN":["0004-2730"],"issn-type":[{"value":"0004-2730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}